Klivira
Request demo

Navigating UnitedHealthcare Entyvio Prior Authorization

Effectively managing UnitedHealthcare Entyvio prior authorization is crucial for ensuring timely patient access to this critical therapy and optimizing revenue cycle performance.

For revenue cycle directors and prior authorization coordinators, securing timely approvals for high-cost specialty medications like Entyvio requires a deep understanding of payer-specific requirements. UnitedHealthcare, as the largest U.S. health insurer, presents a complex landscape of medical and pharmacy benefit PA processes. Klivira helps automate these workflows, integrating directly with UHC's systems where possible.

Entyvio: A High-Volume Prior Authorization Target

Entyvio (vedolizumab) is a biologic medication used to treat ulcerative colitis and Crohn's disease, often requiring prior authorization across commercial, Medicare Advantage, and Medicaid managed care plans. Its high cost and specific clinical criteria make efficient PA submission critical for patient care continuity and financial health.

UnitedHealthcare Prior Authorization Submission Channels

UnitedHealthcare offers multiple pathways for prior authorization. Medical benefit PAs, including those for infused specialty drugs like Entyvio, are primarily submitted via the UnitedHealthcare Provider Portal at uhcprovider.com, which supports member lookup, PA initiation, and document upload. X12 278 transactions are also accepted through clearinghouses for eligible procedures. Pharmacy benefit PAs, managed by OptumRx, typically route through OptumRx's provider PA system or CoverMyMeds and Surescripts for prescriber-initiated ePA.

Specialty Drug Considerations for Entyvio under UnitedHealthcare

For specialty injectables and infusions such as Entyvio, UnitedHealthcare often splits coverage between the medical benefit and the pharmacy benefit, with Optum Specialty Pharmacy handling many pharmacy benefit specialty drugs. This distinction is therapeutic-class specific and can involve site-of-care policies. Providers must verify the current Specialty Pharmacy Drug Program list to determine the appropriate submission channel and coverage rules, which Klivira's platform helps to navigate.

Accessing UnitedHealthcare Medical Necessity Criteria for Entyvio

UnitedHealthcare publishes its medical necessity criteria and coverage rules through its public Medical Policy Library. These policies, which may reference external standards like MCG or NCCN compendium for oncology, outline the clinical indications, step therapy requirements, and other conditions for Entyvio coverage. Accurate citation of the specific policy number and effective date is essential for successful prior authorization submissions.

Understanding UnitedHealthcare PA Turnaround Times and Electronic PA Initiatives

Prior authorization turnaround times for UnitedHealthcare are influenced by state insurance regulations, payer-published service-level targets, and NCQA Utilization Management accreditation standards. For Medicare Advantage and Medicaid managed care plans, CMS-0057-F mandates 72-hour decisions for standard PA and 24-hour for expedited PA, with phased compliance through 2027. UnitedHealthcare is also a key participant in the HL7 Da Vinci Project, exploring Da Vinci PAS, CRD, and DTR to enhance electronic prior authorization capabilities.

Common Denial Reasons and Appeal Pathways for Specialty Drugs

Denials for specialty drugs like Entyvio often stem from medical necessity issues, insufficient clinical documentation, failure to meet step therapy requirements, or site-of-service mismatches. UnitedHealthcare returns denial reasons via X12 277/835 transactions or portal updates. Providers can pursue appeals, with pathways differing by line of business (commercial, MA, Medicaid). Peer-to-peer reviews are available for clinical denials, and expedited appeal options exist for urgent care needs, as documented in UHC's provider administrative guides.

Frequently asked questions

What is the primary portal for submitting Entyvio prior authorizations to UnitedHealthcare?

The primary portal for medical benefit prior authorizations, including for infused specialty drugs like Entyvio, is the UnitedHealthcare Provider Portal at uhcprovider.com. For pharmacy benefit PAs, submissions often route through the OptumRx provider PA system or ePA partners like CoverMyMeds and Surescripts.

How does UnitedHealthcare distinguish between medical and pharmacy benefit coverage for specialty drugs like Entyvio?

UnitedHealthcare, through OptumRx and Optum Specialty Pharmacy, determines coverage for specialty drugs like Entyvio based on the therapeutic category. This can impact whether the drug falls under the medical or pharmacy benefit, often with specific site-of-care policies. Providers should consult the current Specialty Pharmacy Drug Program list.

Are X12 278 transactions supported for Entyvio prior authorizations with UnitedHealthcare?

Yes, UnitedHealthcare accepts X12 278 transactions via clearinghouses for medical benefit prior authorizations, including for eligible procedures and services related to specialty drugs. This electronic submission method can streamline the PA process for integrated systems.

What external criteria sources does UnitedHealthcare use for medical necessity policies?

UnitedHealthcare's Medical Policy Library may reference external criteria sources such as MCG (formerly Milliman Care Guidelines) for general medical policies and the NCCN compendium for oncology drugs. It is crucial to refer to the specific policy for the exact criteria applicable to Entyvio.

How does CMS-0057-F impact UnitedHealthcare's prior authorization for Entyvio?

CMS-0057-F impacts UnitedHealthcare's Medicare Advantage, Medicaid managed care (Community Plan), CHIP, and QHP-on-FFM lines of business. For these plans, the rule mandates shorter turnaround times (72-hour standard, 24-hour expedited) and electronic PA API conformance by 2027. UnitedHealthcare's commercial book is not directly impacted by this rule.

Related coverage

Other entyvio prior authorization by payer

Other entyvio prior authorization by specialty

Ready to automate prior auth for this drug?

See how Klivira automates prior authorizations for your team.

Request a demo